Name:
Racemethorphan
Type:
Opioid
AKA:
N/A
Racemethorphan image
Synthetic substance, no natural derivative
IUPAC Logo
Racemethorphan image
Racemethorphan is a synthetic opioid derivative developed for its potential as a cough suppressant. It is a racemic mixture of methorphan isomers, known for its antitussive properties. Its development aimed to improve on existing cough suppressants, though it is less commonly used today due to the availability of more effective and safer options.
Synthetic Substances Image
Racemethorphan, an opioid, is used for cough suppression. As a downer, it induces significant sedation and cough relief. Short-term effects include reduced cough and euphoria, while long-term use can lead to addiction and tolerance. Overdose risks involve severe respiratory depression and potential fatality. Safe dosing involves careful monitoring. Recent findings emphasize its effectiveness in cough suppression and the need for careful use due to addiction risks.
N/A
Racemethorphan, an opioid, affects opioid receptors to provide analgesia and mood alteration. Immediate effects include euphoria and cognitive impairment, with long-term use carrying risks of dependence and mental health issues. Research focuses on its efficacy and potential for abuse.
N/A
Racemethorphan, an opioid analgesic, has had limited use compared to its more well-known counterparts. Opioids have been central to pain management and have a storied history, from ancient opium use to modern pharmaceuticals. Racemethorphan's cultural significance is tied to the broader opioid narrative, including issues of pain treatment, addiction, and regulatory control. While not as prominent in media or public discourse, it represents the challenges and complexities of opioid medications in modern healthcare. Debates about its use often intersect with larger discussions about the opioid epidemic and the need for balanced pain management strategies.
N/A